Right now, I think the Gilead board is nervously working out a strategy to de-risk the $11 billion investment. Would they throw $3 billion at BLT's hep C vaccine ? We will soon know.
Here's an interview done by Fran Kelly for the new hep C treatment - yeah that $1000 a pill, $84000 for the 12 weeks treatment.
http://www.abc.net.au/radionational/programs/breakfast/hep-c-medical-development/5317280
PF, pick up that phone and call Fran Kelly.